COAGULATION FACTORS - REPLACEMENT AND NON-REPLACEMENT THERAPY FOR COAGULOPATHIES
Buyer: PHI INSTITUTE OF TRANSFUSION MEDICINE OF REPUBLIC OF MACEDONIA SKOPJE
Closed. Submission deadline: 6 April 2026.
- Published
- 9 March 2026
- Submission deadline
- 6 April 2026, 11:00
- Place of performance
- Skopje, MK008
- Procedure
- Open procedure
- Notice number
- 00161230-2026
- Reference
- 40c1d8cd-caea-4f66-9ab3-aaecf105455a
- Official source
- Official source
CPV codes
- 33696200Blood-testing reagents
Description
COAGULATION FACTORS - REPLACEMENT AND NON-REPLACEMENT THERAPY FOR COAGULOPATHIES acording tehnical specification
Lots (21)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | Part 1 B02BD02 Coagulation factor VIII of plasma origin 250IE | 33141520 Plasma extracts | — |
| 2 | Part 2 B02BD02 Coagulation factor VIII of plasma origin 500IE | 33141520 Plasma extracts | — |
| 3 | Part 3 B02BD02 Coagulation factor VIII of plasma origin 1000IE | 33141520 Plasma extracts | — |
| 4 | Part 4 B02BD08 Coagulation factor VIIa rekonbinanten (eptacog alfa) | 33141520 Plasma extracts | — |
| 5 | Part 5 B02BD03 Coagulation factor VIII inhibitor bypassing activity 500 IE | 33141520 Plasma extracts | — |
| 6 | Part 6 B02BD04 Coagulation factor IX рекомбинантен 500IE | 33141520 Plasma extracts | — |
| 7 | Part 7 B02BD04 Coagulation factor IX recombinant 1000 IU | 33141520 Plasma extracts | — |
| 8 | Part 8 B02BD04 Coagulation factor IX recombinant 2000 IU | 33141520 Plasma extracts | — |
| 9 | Part 9 B02BD04 Coagulation factor IX od plazmatsko poteklo 500 IU | 33141520 Plasma extracts | — |
| 10 | Part 10 B02BD06 Coagulation factor VIII and von Willebrand factor in combination 1:1 500IE | 33141520 Plasma extracts | — |
| 11 | Part 11 B02BD06 Coagulation factor VIII and von Willebrand factor in combination 1:1 1000IE | 33141520 Plasma extracts | — |
| 12 | Part 12 B02BX06 Emicizumab SRJ | 33141520 Plasma extracts | — |
| 13 | Part 13 B02BD02 Long-acting recombinant factor VIII with Fc fusion protein 1000 IU | 33141520 Plasma extracts | — |
| 14 | Part 14 B02BD02 Long-acting recombinant factor VIII with Fc fusion protein 3000 IU | 33141520 Plasma extracts | — |
| 15 | Part 15 B02BD02 Recombinant factor VIII from human unmodified cells, fourth generation250IU | 33141520 Plasma extracts | — |
| 16 | Part 16 B02BD02 Recombinant factor VIII from human unmodified cells, fourth generation 500IU | 33141520 Plasma extracts | — |
| 17 | Part 17 B02BD02 Recombinant factor VIII from human unmodified cells, fourth generation 1000IU | 33141520 Plasma extracts | — |
| 18 | Part 18 B02BB01 Human Fibrinogen 1g | 33141520 Plasma extracts | — |
| 19 | Part 19 B02BD02 Long-acting pegylated recombinant factor VIII 500IU | 33141520 Plasma extracts | — |
| 20 | Part 20 B02BD02 Long-acting pegylated recombinant factor VIII 1000IU | 33141520 Plasma extracts | — |
| 21 | Part 21 B02BD04 Long-acting recombinant factor IX with Fc fusion protein 1000IU | 33141520 Plasma extracts | — |
Award criteria
- Price — lowest price
Official publications
- TED · 00161230-2026 · 9 March 2026
- OJS · 47/2026 · 9 March 2026
Other tenders from PHI INSTITUTE OF TRANSFUSION MEDICINE OF REPUBLIC OF MACEDONIA SKOPJE
- REAGENTS, MATERIALS AND CALIBRATES FOR THE CONTROL OF BLOOD-BORNE DISEASES FOR THE Alinity i DEVICE ''or equivalent'' by CHEMILUMISSENCE…
- REAGENTS, CONSUMABLES AND CALIBRATORS FOR HEMOSTASIS APPLICABLE TO AUTOMATIC COAGULOMETER BCS-XP OR EQUIVALENT AND CONSUMABLES FOR…
- TESTS AND REAGENTS FOR MOLECULAR SCREENING OF BLOOD DONORS, ORGAN AND TISSUE DONORS APPLICABLE TO THE PROCLEIX PANTHER SYSTEM OR EQUIVALENT
- CONSUMABLES FOR XPRECIA PORTABLE COAGULOMETER OR EQUIVALENT
- 8-COLUMN GEL MICROAGGLUTINATION CARDS BASED ON SAT and GEL TECHNOLOGY, REAGENTS AND CONSUMABLES WITH EQUIPMENT DISCOUNT
- TESTS FOR QUANTITATIVE DETERMINATION OF D-DIMER IN PLASMA APPLICABLE TO CUBE S DEVICES OR EQUIVALENT
- MICROAGGLUTINATION CARDS, REAGENTS AND CONSUMABLES FOR IMMUNOHEMATOLOGY
- REFRIGERATORS FOR STORAGE OF BLOOD AND BLOOD PRODUCTS
- REAGENTS AND CONSUMABLES FOR MOLECULAR TYPING FOR DETERMINATION OF HLA class I and class II antigens for determination of antibodies using…
- REAGENTS, MATERIALS AND CALIBRATES FOR THE CONTROL OF BLOOD-BORNE DISEASES FOR THE Alinity i DEVICE ''or equivalent'' by CHEMILUMISSENCE…
Frequently asked questions
- What is the deadline to bid for this tender?
- The submission deadline is 6 April 2026, 11:00. Check the official source, as dates can be modified.
- Who is the buyer of this tender?
- The contracting authority is PHI INSTITUTE OF TRANSFUSION MEDICINE OF REPUBLIC OF MACEDONIA SKOPJE (European Union).
- How can I bid for public tenders in the European Union?
- Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the European Union that match your business, every day.
Create a free account and receive new public tenders published in the European Union that match your business, every day.